|
|
||||||||
The Journal of Immunology, Vol 159, Issue 2 846-852, Copyright © 1997 by American Association of Immunologists
ARTICLES |
JC Poe, DH Wagner Jr, RW Miller, RD Stout and J Suttles
Department of Biochemistry, James H. Quillen College of Medicine, East Tennessee State University, Johnson City 37614, USA.
Previous studies have demonstrated that the interaction of CD40 on monocytes with CD40 ligand, present on activated CD4+ T cells, induces monocyte inflammatory cytokine synthesis and rescues monocytes from apoptosis. These findings suggest a role for CD40 signaling of monocyte activation in the maintenance and/or exacerbation of nonseptic (e.g., autoimmune) inflammatory responses. In the present study the effects of the modulatory cytokines IL-4 and IL-10 on CD40-mediated signaling of monocyte IL-1beta synthesis and rescue from apoptosis were examined. Both IL-4 and IL-10 decreased CD40-dependent IL-1beta synthesis in a dose-dependent manner individually and synergized in this effect when used concurrently, with minimal effect on CD40 surface expression. CD40 signaling of IL-1beta synthesis was shown to be dependent on the induction of protein tyrosine kinase (PTK) activity, and both IL-4 and IL-10 diminished CD40-mediated tyrosine phosphorylation of monocyte cellular proteins. However, IL-4, but not IL-10, blocked CD40-mediated rescue from apoptosis, an event that we have demonstrated previously to be dependent on PTK activity as well. Together these results suggest that in monocytes 1) both IL-4 and IL-10 target CD40-induced PTK activity in the down-regulation of IL-1beta synthesis; and 2) IL-4 and IL-10 have divergent effects on the CD40 signaling pathway, in that these cytokines are synergistic with respect to their abilities to inhibit CD40-mediated IL-1beta synthesis and differ in their abilities to block CD40-mediated rescue from apoptosis.
This article has been cited by other articles:
![]() |
H.R.S. Girn, N.M. Orsi, and S. Homer-Vanniasinkam An overview of cytokine interactions in atherosclerosis and implications for peripheral arterial disease Vascular Medicine, November 1, 2007; 12(4): 299 - 309. [Abstract] [PDF] |
||||
![]() |
C.-H. Hsing, C.-C. Hsu, W.-Y. Chen, L.-Y. Chang, J.-C. Hwang, and M.-S. Chang Expression of IL-19 correlates with Th2 cytokines in uraemic patients Nephrol. Dial. Transplant., August 1, 2007; 22(8): 2230 - 2238. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Mukundan, G. A. Bishop, K. Z. Head, L. Zhang, L. M. Wahl, and J. Suttles TNF Receptor-Associated Factor 6 Is an Essential Mediator of CD40-Activated Proinflammatory Pathways in Monocytes and Macrophages J. Immunol., January 15, 2005; 174(2): 1081 - 1090. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. L. W. Chang, N. Baumgarth, D. Yu, and P. A. Barry Human Cytomegalovirus-Encoded Interleukin-10 Homolog Inhibits Maturation of Dendritic Cells and Alters Their Functionality J. Virol., August 15, 2004; 78(16): 8720 - 8731. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Inoue, T. Otsuka, H. Niiro, S. Nagano, Y. Arinobu, E. Ogami, M. Akahoshi, K. Miyake, I. Ninomiya, S. Shimizu, et al. Novel Regulatory Mechanisms of CD40-Induced Prostanoid Synthesis by IL-4 and IL-10 in Human Monocytes J. Immunol., February 15, 2004; 172(4): 2147 - 2154. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Wille, E. N. Villegas, L. Craig, R. Peach, and C. A. Hunter Contribution of Interleukin-12 (IL-12) and the CD28/B7 and CD40/CD40 Ligand Pathways to the Development of a Pathological T-Cell Response in IL-10-Deficient Mice Infect. Immun., December 1, 2002; 70(12): 6940 - 6947. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E. Jones, M. R. Ackermann, U. Wille, C. A. Hunter, and P. Scott Early Enhanced Th1 Response after Leishmania amazonensis Infection of C57BL/6 Interleukin-10-Deficient Mice Does Not Lead to Resolution of Infection Infect. Immun., April 1, 2002; 70(4): 2151 - 2158. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. H. Wagner Jr., G. Vaitaitis, R. Sanderson, M. Poulin, C. Dobbs, and K. Haskins Expression of CD40 identifies a unique pathogenic T cell population in type 1 diabetes PNAS, March 19, 2002; 99(6): 3782 - 3787. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. D. Brown, B. S. Hostager, and G. A. Bishop Differential Signaling and Tumor Necrosis Factor Receptor-associated Factor (TRAF) Degradation Mediated by CD40 and the Epstein-Barr Virus Oncoprotein Latent Membrane Protein 1 (LMP1) J. Exp. Med., April 16, 2001; 193(8): 943 - 954. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Wolk, W.-D. Docke, V. von Baehr, H.-D. Volk, and R. Sabat Impaired antigen presentation by human monocytes during endotoxin tolerance Blood, July 1, 2000; 96(1): 218 - 223. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. N. Villegas, U. Wille, L. Craig, P. S. Linsley, D. M. Rennick, R. Peach, and C. A. Hunter Blockade of Costimulation Prevents Infection-Induced Immunopathology in Interleukin-10-Deficient Mice Infect. Immun., May 1, 2000; 68(5): 2837 - 2844. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Hayashida, Y. Shimaoka, T. Ochi, and P. E Lipsky Rheumatoid Arthritis Synovial Stromal Cells Inhibit Apoptosis and Up-Regulate Bcl-xL Expression by B Cells in a CD49/CD29-CD106-Dependent Mechanism J. Immunol., January 15, 2000; 164(2): 1110 - 1116. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. G. Schottelius, M. W. Mayo, R. B. Sartor, and A. S. Baldwin Jr. Interleukin-10 Signaling Blocks Inhibitor of kappa B Kinase Activity and Nuclear Factor kappa B DNA Binding J. Biol. Chem., November 5, 1999; 274(45): 31868 - 31874. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Suttles, D. M. Milhorn, R. W. Miller, J. C. Poe, L. M. Wahl, and R. D. Stout CD40 Signaling of Monocyte Inflammatory Cytokine Synthesis through an ERK1/2-dependent Pathway. A TARGET OF INTERLEUKIN ()-4 AND IL-10 ANTI-INFLAMMATORY ACTION J. Biol. Chem., February 26, 1999; 274(9): 5835 - 5842. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Jain-Vora, A. M. LeVine, Z. Chroneos, G. F. Ross, W. M. Hull, and J. A. Whitsett Interleukin-4 Enhances Pulmonary Clearance of Pseudomonas aeruginosa Infect. Immun., September 1, 1998; 66(9): 4229 - 4236. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |